EP2480085

Combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    23.9.2010
  • EP published:
    12.11.2014
  • EP application number:
    10819438.2
  • Max expiry date:
    22.9.2030
  • Title:
    Combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide

Timeline

Today
23.9.2010EP application
12.11.2014EP Publication

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056, Basel, CH

Inventor

  • Name:
    DUMBLE, Melissa
  • Address:
    PiscatawayNJ, US
  • Name:
    GILMER, Tona
  • Address:
    Research Triangle ParkNC, US
  • Name:
    KUMAR, Rakesh
  • Address:
    CollegevillePA, US
  • Name:
    LEBOWITZ, Peter, F.
  • Address:
    CollegevillePA, US
  • Name:
    MORRIS, Shannon, Renae
  • Address:
    Research Triangle ParkNC, US
  • Name:
    LAQUERRE, Sylvie
  • Address:
    King Of PrussiaPA, US

Priority

  • Number:
    245027 P
  • Date:
    23.9.2009
  • Country:
    US

Classification

  • Categories:
    A01N 43/54, A61K 31/415, A61K 31/505

Upload documents